Store

Home | Store | 2024 Nuclear Medicine Market Outlook Report
brand-logo

2024 Nuclear Medicine Market Outlook Report

Publication Date: May 14, 2025

SKU: 24-062

Tags: Nuclear Medicine

Pages: 138

SKU: 24-062

X

IMV’s 2024 Nuclear Medicine Market Outlook examines nuclear medicine procedure volumes, purchase plans, and buying criteria for future nuclear medicine purchases. Learn how NM administrators feel about their department’s future outlook and how they prioritize their goals in light of industry challenges. The report explores nuclear medicine market trends, including NM procedure volume, installed base features, use of OEM vs. third-party service providers, equipment purchase plans, radiopharmaceutical utilization/budgets, theranostics, and site operations characteristics. Survey results are projected to the identified universe of NM facilities, and the report provides market forecast scenarios for NM scanners for 2024-2026.

What you’ll learn in this report

Nuclear medicine department priorities and future outlook

  • What are the key department priorities for NM?
  • What factors will impact the outlook for NM the most?
  • What are the preferred info sources for future NM purchases?
  • What are the top-ranked preferred uses of AI for NM?

Nuclear medicine procedures

  • How has NM volume changed in 2024?
  • What is the trend in NM procedure mix by procedure type?

NM scanner installed base and purchase plans

  • How many fixed NM units are installed by site type?
  • What is the trend in installed base market share by vendor?
  • What is the adoption rate for key NM capabilities?
  • What is the anticipated age of NM units upon replacement?
  • What is the mix of new vs. refurbished NM scanners?
  • What type of service providers are NM sites using?
  • What is the brand loyalty of current NM users?
  • What are the key buying criteria for future NM scanners?
  • What is the unit forecast for NM scanners for 2024 to 2026?

Theranostics

  • What are the most common theranostics procedures?
  • Which radiopharmacueticals are utilized the most?

Site operations characteristics

  • How many technologists, nurses, administrators, imaging aides, and secretaries are employed in NM departments?
  • What % of sites & procedures use outside reading services

Market Research Methodology

This report utilizes the results from an IMV-hosted online survey conducted in January/March 2024 with 340 NM administrators, supervisors, and chief technologists from a random sample of hospitals and imaging centers in the US.

2024 NUCLEAR MEDICINE MARKET OUTLOOK REPORT

 

EXHIBIT

A.            Nuclear Medicine Department Priorities & Future Outlook                                                 13
  1. Priorities to the Mission of Nuclear Medicine Departments Over the Next Year, as of 2024 Survey 14
  2. Hospitals vs. Non-Hospitals: Priorities to the Mission of Nuclear Medicine Departments Over the Next Year, as of 2024 Survey 15
  3. Priorities to the Mission of Nuclear Medicine Departments Over the Next Year, by IMV

Study Year, 2011 to 2024                                                                                                       16

  1. Summary of Open-Ended Responses for NM Department Priorities 17
  2. Factors Affecting the Future Outlook for Nuclear Medicine at your Facility Over the Next Few Years, as of 2024 Survey 18
  3. Hospitals vs. Non-Hospitals: Factors Affecting the Future Outlook for Nuclear Medicine at

Your Facility Over the Next Few Years, as of 2024 Survey                                                       19

  1. Factors Affecting the Future Outlook for Nuclear Medicine at your Facility Over the Next Few Years, by IMV Study Year, 2011 to 2024 20
  2. Summary of Open-Ended Responses for Future Outlook Factors 21
  3. Priority Ranking for Using Artificial Intelligence and Machine Learning Tools in NM Departments, as of 2024 Survey 22
  4. Current Use and Consideration of Artificial Intelligence and Machine Learning Tools

In NM Departments, as of 2024 Survey                                                                                   23

  1. Current Use and Consideration of Artificial Intelligence and Machine Learning Tools

In Nuclear Medicine Departments, by Hospital vs. Non-Hospital, as of 2024 Survey                   24

  1. Outlook for NM Procedures, Reimbursement, Revenue, and Net Income, as of 2024 Survey 25
  2. Outlook for NM Procedure Volume, by IMV Study Year, 2011 to 2024 26
  3. Outlook for NM Reimbursement Levels, by IMV Study Year, 2011 to 2024 26
  4. Outlook for NM Revenue, by IMV Study Year, 2011 to 2024 26
  5. Outlook for NM Net Income, by IMV Study Year, 2011 to 2024 26
  6. Strategic Actions Being Considered Over the Next Few Years, as of 2024 Survey                   27
  7. Strategic Actions Being Considered Over the Next Few Years by Hospitals vs.

Non-Hospitals, as of 2024 Survey                                                                                           28

  1. Summary of Product Suggestions – Open-Ended Responses 29
  2. Relative Impact of Covid-19 on Department when managing NM operations,

as of 2024 Survey                                                                                                                  30

  1. Relative Impact of COVID-19 on Department When Managing NM Operations,

by IMV Survey Year                                                                                                               31

  1. Relative Impact of COVID-19 on Department when Managing NM Operations,

by Site Type, as of 2024 Survey                                                                                             31

 

B.            Nuclear Medicine Patient Study Volume                                                                            32
  1. Total Nuclear Medicine Patient Studies, Hospital and Non-Hospital Sites, 2002-2023 33
  2. Distribution of Nuclear Medicine Sites and Patient Studies, by Site Type, 2023 34
  3. Distribution of Nuclear Medicine Sites, by Patient Study Volume Ranges, by Site Type, 2023 35
  4. Trend in Average Nuclear Medicine Patients per Site, by Site Type, 2012-2023 35
  5. Distribution of 2023 Nuclear Medicine Patient Studies Performed on SPECT/CT, SPECT-only and Planar-only Cameras, by Site Type 36
  6. Types of Nuclear Medicine Clinical Applications Currently Provided or Planned Over the

Next Three Years, as of 2024 Survey                                                                                      37

  1. Types of Nuclear Medicine Clinical Applications Currently Provided or Planned Over the

Next Three Years, by Site Type, as of 2024 Survey                                                                 38

  1. Types of Nuclear Medicine Clinical Applications Currently Provided or Planned Over the

Next Three Years, by Site Type, as of 2024 Survey                                                                 39

  1. Nuclear Medicine 2023 Patient Study Mix, by Procedure Category, All Sites,

as of 2024 Survey                                                                                                                  40

  1. Distribution of Nuclear Medicine Patient Studies, by Procedure Type, 2012-2023 41
  2. Whether the Total Number of NM Patient Studies in 2024 is Anticipated to Increase, Stay the Same, or Decrease, Compared to 2021, by Site Type 43
  3. Whether Proportion of NM Patient Studies Will Increase, Stay the Same, or Decrease in 2024 Compared to 2023, by Procedure Type 44
  4. Whether Proportion of Myocardial Perfusion Studies Will Increase, Stay the Same, or Decrease in 2024 Compared to 2023, by Site Type 44
  5. Percent of Sites Performing Nuclear Medicine Studies, by Procedure Type,

Hospitals and Non-Hospitals, as of 2024 Survey                                                                   45

  1. Average Number of Nuclear Medicine Patient Studies per Site Performing, by Procedure

Type, Hospitals vs. Non-Hospitals, 2024 Survey                                                                      45

  1. Percent of Sites Performing Nuclear Medicine Studies, by Procedure Type, by IMV Study

Year, 2010 to 2023                                                                                                                46

  1. Mix of Inpatient, Outpatient, vs. Emergency Nuclear Medicine Patient Studies, by Site Type, 2023             47
  2. Percentage of SPECT/CT Sites Performing Patient Studies with Diagnostic CT Scans, as of 2024 Survey 48
  3. Percentage of SPECT/CT Sites Performing Diagnostic CT Scans, by SPECT/CT Patient

Study Ranges, as of 2024 Survey                                                                                           48

  1. Percentage of SPECT/CT Sites Performing Diagnostic CT-only Scans with No Associated SPECT Scans, as of 2024 Survey 49
  2. Percentage of SPECT/CT Sites Performing Diagnostic CT-only Scans with No Associated SPECT Scans, by SPECT/CT Patient Study Ranges, as of 2024 Survey 49

 

C.            Radiopharmaceuticals & Pharmacological Stress Agents                                                  50

  1. Facilities Performing Radionuclide Therapy, by Site Type, as of 2024 Survey 51
  2. Radionuclide Therapy: Distribution of Nuclear Medicine Sites Performing and Procedures

Performed, by Site Type, 2023                                                                                               52

  1. Average Annual Number of Radionuclide Therapy Procedures per Site Performing,

by Site Type, 2023                                                                                                                 52

  1. Percentage of Radionuclide Therapy Sites Using Specific Radionuclide Therapy Agents,

2024                                                                                                                                      53

  1. Radionuclide Therapy Procedure Volume, by Radioactive Agent, 2023 53
  2. Facilities Performing Theranostics, by Site Type, as of 2024 Survey 54
  3. Theranostics: Distribution of Nuclear Medicine Sites Performing and Procedures Performed,

by Site Type, 2023                                                                                                                 55

  1. Average Annual Number of Theranostics Procedures per Site Performing, by Site Type,

2023                                                                                                                                      55

  1. Percentage of Theranostics Sites Using Specific Radioactive Agents, 2024 56
  2. Theranostics Procedure Volume, by Radioactive Agent, 2023 56
  3. Whether PSMA Radiopharmaceuticals Are Used for NM Studies in Your Department,

as of 2024 Survey                                                                                                                  57

  1. Myocardial Perfusion Studies: Distribution of Nuclear Medicine Sites Performing and

Patient Studies Performed, by Site Type, as of 2024 Survey                                                     58

  1. Trend in the Mix of Myocardial Perfusion Studies, by Site Type, 2012-2023 58
  2. Radioactive Agents Used for Myocardial Perfusion Studies, Including Single & Dual
  3. Isotopes, 2023 59
  4. Trend in Percentage of Myocardial Perfusion Studies Using Single vs. Dual Isotopes,

2012-2023                                                                                                                             59

  1. Percent of Myocardial Perfusion Studies Using Single vs. Dual Isotopes,

by Site Type, 2023                                                                                                                 60

  1. Percentage of Myocardial Perfusion Studies Using Specified Agents, 2012-2023 61
  2. Percentage of Myocardial Perfusion Patient Studies, by Injection Type, 2023 61
  3. Percentage of Sites Providing Perfusion Injections, by Injection Type, 2023 62
  4. Percentage of Sites Providing Perfusion Injections, by Injection Type, 2024 62
  5. Distribution of Perfusion Injections, by Isotope, by Site Type, 2023 63
  6. Distribution of Perfusion Injections, by Isotope, 2012-2023 63
  7. Whether the Proportion of Myocardial Perfusion Patient Studies Using Technetium-99m

Agents Will Increase, Stay the Same, or Decrease in 2024, Compared to 2023                         64

  1. Distribution of 2023 Myocardial Perfusion Patient Studies, by Whether Imaged with Stress

or Not, by Site Type                                                                                                               65

  1. Distribution of 2023 Myocardial Perfusion Patient Studies, by Stress Mode, Hospitals and

Non-Hospitals                                                                                                                        66

  1. Trend in Distribution of Myocardial Perfusion Patient Studies, by Stress Mode, 2010-2023 66
  2. Percent of Myocardial Perfusion Pharmacological Stress Patient Studies,

by Stress Agent by Site Type, 2023                                                                                        67

  1. Percent of Sites Using Specific Pharmacological Stress Agents, by Site Type, 2023 67
  2. Distribution of 2024 Radiopharmaceutical Budgets 68
  3. Distribution of 2024 Radiopharmaceutical Budgets, by Site Type 68
  4. Radiopharmaceutical Expenditures, Hospital and Non-Hospital Sites, 2011-2024 69
  5. Average Radiopharmaceutical Expenditures per Site and per Patient Study,

by Site Type, 2024                                                                                                                 70

  1. Whether the Price Per Patient Dose for Technetium-99m Agents Will Increase,

Stay the Same, or Decrease in 2024, Compared to 2023                                                         71

  1. Radiopharmaceutical Expenditure Trend by Distribution Source, by Budget Year,

2010-2023                                                                                                                             72

  1. Distribution of Nuclear Medicine Sites, by Source of Radiopharmaceuticals,

by Site Type, as of 2024 Survey                                                                                             72

  1. Supplier Share of 2023 Radiopharmaceutical Expenditures 73
  2. Trend in Supplier Share of Radiopharmaceuticals Purchased from Radiopharmacies,

2010-2023                                                                                                                             73

 

D.            Nuclear Medicine Camera Installed Base                                                                           74
  1. Distribution of Nuclear Medicine Sites and Cameras, Hospital & Non-Hospital Sites,
    as of 2024 Survey 75
  2. Trend in Installed Base of Nuclear Medicine Cameras, Hospitals & Non-Hospital Sites,

by IMV Study Year, 2011 to 2024                                                                                            76

  1. Distribution of Sites, by Number of Nuclear Medicine Cameras Installed, by Site Type,
    as of 2024 Survey 77
  2. Nuclear Medicine Camera Installed Base Share, as of 2024 Survey 78
  3. Trend in Nuclear Medicine Camera Installed Base Share, by IMV Study Year,

1995 to 2024                                                                                                                         78

  1. Distribution of Nuclear Medicine Camera Installed Base, by Year of Installation,

as of 2024 Survey                                                                                                                  79

  1. Distribution of Nuclear Medicine Camera Installed Base, by Year of Installation,

by Site Type, as of 2024 Survey                                                                                             80

  1. Distribution of Nuclear Medicine Camera Installed Base, by Camera Type, by Site Type,

as of 2024 Survey                                                                                                                  81

  1. Trend in Nuclear Medicine Camera Installed Base Mix, by Camera Type,

by IMV Study Year, 2011 to 2024                                                                                            82

  1. Nuclear Medicine Camera Installed Base Share, by Camera Type, as of 2024 Survey 83
  2. SPECT Camera Installed Base Share, by Single-, Dual-, and Triple-Head Camera Types,

as of 2024 Survey                                                                                                                  83

  1. Nuclear Medicine Camera Installed Base Share, by Installation Time Frames for Units

Currently Installed, as of 2024 Survey                                                                                     84

  1. Distribution of Installed SPECT/CT Cameras, by Number of CT Slices, as of 2024 Survey 85
  2. Distribution of Installed SPECT/CT Cameras, by Number of CT Slices, by Site Type,

as of 2024 Survey                                                                                                                  85

  1. Whether the SPECT or SPECT/CT is a General Purpose or Dedicated Cardiac Camera,

by Site Type, as of 2024 Survey                                                                                             86

  1. Whether the SPECT or SPECT/CT is a General Purpose or Dedicated Cardiac Camera,

by Camera Type, as of 2024 Survey                                                                                       86

  1. Whether SPECT or SPECT/CT Camera has Solid State Detector, by Site Type,

as of 2024 Survey                                                                                                                  87

  1. Whether SPECT or SPECT/CT Camera has Solid State Detector, by Camera Type,

as of 2024 Survey                                                                                                                  87

  1. Whether the SPECT or SPECT/CT was Originally Purchased New or Refurbished/Used,

by Site Type, as of 2024 Survey                                                                                             88

  1. Whether the SPECT or SPECT/CT was Originally Purchased New or Refurbished/Used,

by Camera Type, as of 2024 Survey                                                                                       88

  1. Distribution of Sources for Primary Service Support of Nuclear Medicine Cameras,            by Site Type, as of 2024 Survey                                                                                                                      89
  2. Distribution of Sources for Primary Service Support of Nuclear Medicine Cameras,         by Camera Type, as of 2024 Survey                                                                                                                  89
  3. Distribution of Sources for Primary Service Support of Nuclear Medicine Cameras,

by Year of Installation, as of 2024 Survey                                                                                90

  1. Type of Service Contractual Arrangement for Nuclear Medicine Cameras, by Site Type,

as of 2024 Survey                                                                                                                  91

  1. Type of Service Contractual Arrangement for Nuclear Medicine Cameras,by Camera Type,

as of 2024 Survey                                                                                                                  91

  1. Primary Source of NM Service Support, by Whether the SPECT or SPECT/CT was

Originally Purchased New or Refurbished/Used, as of 2024 Survey                                          92

  1. Type of Service Contractual Arrangements with Outside NM Service Providers,

by Primary Source of NM Service Support, as of 2024 Survey                                                  92

  1. Whether There Are NM Cameras Owned/Managed by Department in Other Hospitals,

as of 2024 Survey                                                                                                                  93

  1. Number of NM Cameras Owned/Managed by Department in Other Hospitals, as of 2024 Survey 93
  2. Whether There Are NM Cameras Owned/Managed by Department in Imaging Centers or Outpatient/Office Locations, as of 2024 Survey 94
  3. Types of Imaging Centers and Outpatient/Office Locations Where Nuclear Medicine

Camera is Owned/Managed by Department, as of 2024 Survey                                                94

  1. Number of NM Cameras in Imaging Centers or Outpatient/Office Locations

Owned/Managed by Department, as of 2024 Survey                                                                94

  1. Whether There are Other Locations Where Nuclear Medicine Cameras are Installed,

But Not Owned/Managed by Department, as of 2024 Survey                                                    95

  1. Other Locations Where Nuclear Medicine Camera is Installed, But Not Owned/Managed

by Department, as of 2024 Survey                                                                                          95

 

  1. Nuclear Medicine Camera Purchase Plans & Market Scenarios 96
    1. Purchase Plans for Nuclear Medicine Cameras Over the Next Three Years,

as of 2024 Survey                                                                                                                  97

  1. Percent of Sites Planning to Purchase Nuclear Medicine Cameras Over the Next Three

Years, by IMV Study Year, 2011 to 2024                                                                                 98

  1. Percent of Sites Planning to Purchase Nuclear Medicine Cameras from 2024 to 2024,

by Site Type, as of 2024 Survey                                                                                             98

  1. Type of Nuclear Medicine Camera Planned for Purchase, as of 2024 Survey 99
  2. Type of Nuclear Medicine Camera Planned for Purchase, by Site Type,       as of 2024 Survey                                                                                                                                  99
  3. Trend in Type of Nuclear Medicine Camera Planned for Purchase,by IMV Study Year,

2011 to 2024                                                                                                                       100

  1. Whether Planned Nuclear Medicine Camera Will be a General Purpose or Dedicated

Cardiac Camera, as of 2024 Survey                                                                                      101

  1. Whether Planned Nuclear Medicine Camera will be a General Purpose or Dedicated

Cardiac Camera, by Site Type, as of 2024 Survey                                                                  101

  1. Planned SPECT/CT Purchases, by Number of Slices, as of 2024 Survey 102
  2. Whether Planned SPECT/CT Units will be Used for Diagnostic CT Purposes,

as of 2024 Survey                                                                                                                102

  1. Plans for New vs. Refurbished/Used Nuclear Medicine Cameras, by Site Type,

as of 2024 Survey                                                                                                                103

  1. Plans for New vs. Refurbished/Used Nuclear Medicine Cameras, by Camera Type Planned,

as of 2024 Survey                                                                                                                103

  1. Plans for Replacement and Additional Nuclear Medicine Cameras, by Site Type,

as of 2024 Survey                                                                                                                104

  1. Percent Distribution of Sites Mentioning Manufacturers Considered for Next Nuclear

Medicine Camera Purchase, as of 2024 Survey                                                                     105

  1. Trend in Percent Distribution of Sites Mentioning Manufacturers Considered for Next NM Camera Purchase, by IMV Study Year, 2011 to 2024 105
  2. Brand Loyalty: Nuclear Medicine Camera Manufacturers Being Considered,

by Current Camera Installed Base, as of 2024 Survey                                                            106

  1. Annual 2024-2024 Budget Status for NM Cameras Planned for Purchase,

as of 2024 Survey                                                                                                                107

  1. Distribution of 2024 Nuclear Medicine Equipment Budgets, All Sites 108
  2. Distribution of 2024 Nuclear Medicine Equipment Budgets, by Site Type,

as of 2024 Survey                                                                                                                108

  1. Nuclear Medicine Equipment Budget Trend, 2011-2024 Budget Years 109
  2. Distribution of 2023-2026 NM Equipment Budgets, as of 2024 Survey 110
  3. Average Nuclear Medicine Equipment Budget per Site, for Sites Having Budgets >$0,

by Site Type, 2011-2024                                                                                                       111

  1. Whether Hospital Plans to Purchase NM Cameras Located Outside the Main Hospital that

Department Will Own/Manage, as of 2024 Survey                                                                  112

  1. Other Locations for Planned NM Cameras to be Owned/Managed by Department,

as of 2024 Survey                                                                                                                112

  1. Number of NM Cameras Planned for Purchase for Other Locations that will be Owned/Managed by Responding Department, as of 2024 Survey 112
  2. Whether Hospital Plans to Purchase NM Cameras in Other Locations that Department Will NOT Own/Manage, as of 2024 Survey 113
  3. Other Locations for Planned NM Cameras NOT Owned/Managed by Department,

as of 2024 Survey                                                                                                                113

  1. Percentage of Sites Planning to Complete Capital Projects from 2024-2026,

as of 2024 Survey                                                                                                                114

  1. Whether Capital Project Will Include Capital Expenditures for NM Cameras in the Project

Plan, as of 2024 Survey                                                                                                        114

  1. Nuclear Medicine Replacement Cycle, Based on 2024 Survey Responses 115
  2. Average Age of NM Cameras Upon Replacement, by IMV Study Year, 2011 to 2024 115

 

  1. Demographics & Site Operations Characteristics 116
    1. Non-Hospital vs. Hospital Mix of Nuclear Medicine Locations, as of 2024 Survey 117
    2. Ownership of “Physician Office Locations,” as of 2024 Survey 117
    3. Hospital Bed Size Mix of Hospital-Based Nuclear Medicine Locations, as of 2024 Survey 118
    4. Hospital Ownership Type, by Bed Size, as of 2024 Survey 118
    5. Hospital Department Operating NM Equipment, by Bed Size, as of 2024 Survey 118
    6. Academic/University Hospital Status, by Bed Size, as of 2024 Survey 118
    7. Urban/Suburban/Rural Locations, by Site Type, as of 2024 Survey 119
    8. Percent of Nuclear Medicine Sites with Specified Staff Types, by Site Type,

as of 2024 Survey                                                                                                                120

  1. Mean Number of Employees per Nuclear Medicine Site Having that Type, by Site Type,

as of 2024 Survey                                                                                                                120

  1. Whether Facility has a Nuclear Medicine Physicist on Staff, by Site Type,

as of 2024 Survey                                                                                                                121

  1. Distribution of Sites, by Number of Physicians that Read Nuclear Medicine Studies,

by Site Type, as of 2024 Survey                                                                                           122

  1. Average 2023 NM Patient Studies Read per Physician, by Site Type,

as of 2024 Survey                                                                                                                122

  1. Specialties of Physicians who Read Nuclear Medicine Studies, by Site Type,

as of 2024 Survey                                                                                                                123

  1. Percentage of Sites Using Outside Reading Services, On-Site Physicians vs. Off-Site Physicians to Read Nuclear Medicine Studies, by Site Type, as of 2024 Survey 124
  2. Percentage of NM Studies Read On-Site by Physicians, Read Off-Site by Physicians, or

Off-Site by Outside Reading Service, by Site Type, as of 2024 Survey                                    124

  1. Types of Digital Workstations Used by Physicians for Reading and Interpreting NM Exams,

by Site Type, as of 2024 Survey                                                                                            125

  1. Financial Health of Nuclear Medicine Department in 2024, by Site Type 126
  2. Financial Health of Nuclear Medicine Department in Recent Years, as of 2024 Survey 127
  3. Whether Nuclear Medicine Department is at Optimal Staffing Levels, as of 2024 Survey 128
  4. Level of Staffing Challenges in Nuclear Medicine Department, by Site Type,

As of 2024 Survey                                                                                                                129

  1. Average Waiting Time for a Non-Emergency NM Outpatient Visit, by IMV Study Year,

2011 to 2024                                                                                                                       130

  1. Hours per Weekday Nuclear Medicine Department Open for Scheduled Procedures,
    by Site Type, as of 2024 Survey 131
  2. Hours per Weekend Nuclear Medicine Department Open for Scheduled Procedures,
    by Site Type, as of 2024 Survey 131
  3. Hours per Weekday Nuclear Medicine Department Open, Including Scheduled,

Unscheduled, and On-Call Procedures, by Site Type, as of 2024 Survey                                 132

  1. Hours per Weekend Nuclear Medicine Department Open, Including Scheduled,

Unscheduled, and On-Call Procedures, by Site Type, as of 2024 Survey                                 132

 

 

  1. Appendix 133
    1. Other NM Department Priorities Mentioned by Respondents – Open-Ended Responses 134
    2. Other Future Outlook Factors – Open-Ended Responses 135
    3. Suggestions for Product Capabilities & Services from NM Equipment or Software/IT

Manufacturers – Open-Ended Responses                                                                             136

  1. About IMV 138

 

Our Knowledge Center provides access to

all market reports

Click here
to learn more

Related products

brand-logo

In Vitro Diagnostic (IVD) Procedure Volumes, 2023-2028

October 22, 2023

Gain invaluable insights into the global IVD market with Kalorama Information’s comprehensive report In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028. This analysis provides essential data on the number of IVD procedures, offering a gold standard for new entrants and existing marketers in the diagnostic products industry.

 

…

Price range: $6,000.00 through $9,000.00

brand-logo

Cell and Gene Therapy Market and Deals Analysis, 2023

May 22, 2023

Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals tracks deal-making and market opportunities in cell and gene therapy, providing specific details of 1000+ deals from 2022-2023. With a staggering $40 billion in CGT deals in 2022 alone, understanding the market dynamics and key…

Price range: $4,000.00 through $6,000.00

brand-logo

The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition

April 23, 2024

Explore the latest trends and forecasts in the point-of-care (POC) diagnostic tests market with Kalorama Information’s The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition. Discover the key growth areas and technological advancements shaping the future of POC diagnostics.

Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in…

Price range: $7,000.00 through $10,000.00

Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028

In recent decades, genetic technologies for research and diagnostics have transformed healthcare, offering new possibilities in precision medicine and disease management. Next-generation sequencing (NGS) has revolutionized genetic disease diagnostics and oncology, providing comprehensive insights at a relatively low cost. PCR continues to evolve, remaining a central tool in molecular diagnostics. In situ hybridization techniques (ISH)…

Price range: $5,000.00 through $7,500.00

Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028

The Worldwide Market for Clinical Laboratory Services, 9th Edition

Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies…

Price range: $5,000.00 through $7,500.00

The Worldwide Market for Clinical Laboratory Services, 9th Edition

In Vitro Diagnostics Business Outlook, 2024

In Vitro Diagnostics Business Outlook, 2024 is a must-have publication offering exclusive information and data that cannot be found elsewhere. With a focus on the in vitro diagnostics (IVD) market, this publication provides valuable insights to help businesses identify growth opportunities, understand market trends, and tailor strategies for success.

 

Key Features: 

…

Price range: $2,950.00 through $7,500.00

In Vitro Diagnostics Business Outlook, 2024